Please login to the form below
Anoro Ellipta
This page shows the latest Anoro Ellipta news and features for those working in and with pharma, biotech and healthcare.
Sovaldi pushes Gilead to the top of US pharma list
The London-based firm has also failed to increase market share for its next-gen versions of Advair - namely Breo, Ellipta and Anoro Ellipta - which had combined sales last year of
Latest news
-
GSK's Anoro first LAMA/LABA approved for COPD in US
Important step towards eventually replacing Seretide/Advair sales. GlaxoSmithKline's (GSK) chronic obstructive pulmonary disease (COPD) portfolio received a significant boost yesterday with the US approval of combination product Anoro Ellipta.
-
GSK’s COPD drug Anoro under review in US
FDA accepts new drug application for the LAMA/LABA combination. GlaxoSmithKline's (GSK) investigational respiratory treatment Anoro is under review by the FDA after the US regulator accepted its new drug ... The US submission follows Anoro's filing with
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
NICE – but not enough
Figure 2 shows the sales of GSK’s respiratory treatment, Anoro Ellipta, across the various availabilities. ... The chart reveals that Anoro Ellipta gets most sales when availability is unrestricted.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Theravance hires BMS veteran Pasqualone
Pasqualone joins Theravance as the company at a crucial time as its development deals with GlaxoSmithKline bears fruit with US approval of respiratory treatment Anoro Ellipta.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Account Management
-
Competitive Salary Offered
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
-
Principal Medical Writer
-
Varies on experience
- Pfizer helps fund biotech venture from former researchers at closed Kent facility
- Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- New restrictions for AZ/Oxford COVID-19 vaccine despite EMA endorsement
- Moderna launches COVID-19 vaccine booster study to address new variants
- UPDATE: AZ/Oxford University COVID-19 vaccine gets EU approval
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- Roche, Regeneron’s COVID-19 antibody cocktail cuts infection risk
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Change for good: the virtual congress audience is too big to be ignored
- 3 tips to show patient diversity in your clinical trial materials
PMHub
Iguazu
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...
Latest intelligence
- 3 tips to show patient diversity in your clinical trial materials
- Here are some useful tips to help get your hands on authentically diverse stock photos....
- Virtual congresses: video thrilled the cardio tsar
- Chris Ross explores the key learnings from a year of virtual congresses...
- When Will We Be Back To Normal?
- The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
Quick links
Infographics
